PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

FDA fast tracks Merck anticoagulant

The U.S. FDA has granted Fast Track designation for Merck’s investigational anticoagulant therapy MK-2060, giving Merck a push in its quest to provide new ...
Continue Reading →
News

Alcon to buy Aerie Pharmaceuticals for $770M

Eye care drug company Alcon and Aerie Pharmaceuticals have entered a definitive merger agreement through which Alcon will acquire Aerie for $770 milli...
Continue Reading →
News

FDA approves Axsome first rapid-acting antidepressant

New York-based biopharma Axsome Therapeutics announced last week that the FDA had approved Auvelity, its oral n-methyl d-aspartate (NDMA) receptor drug dev...
Continue Reading →
News

Gilead grabs its first approval for twice-yearly HIV therapy

The European Commission has become the first regulator worldwide to approve Gilead Sciences' Sunlenca (lenacapavir) — the only twice-yearly add-on dru...
Continue Reading →
News

Merck signs next-gen RNA collab with Orna Therapeutics

Merck (MSD) and biotech startup Orna Therapeutics unveiled a collaboration agreement to discover, develop and commercialize multiple programs, including va...
Continue Reading →
News

NICE recommendation expands patient eligibility for AbbVie’s Ozurdex

Treatment becomes an option for treating visual impairment caused by diabetic macular oedema, regardless of lens status. AbbVie has announced that the National In...
Continue Reading →
News

MHRA authorises Moderna’s omicron-containing bivalent booster

Study results show the candidate has demonstrated significantly higher antibodies against Omicron. Moderna has announced that the Medicines and Healthcare product...
Continue Reading →
News

Santen launches Ducressa for post-cataract surgery

Treatment involves a combination of levofloxacin and dexamethasone for use after cataract surgery. Santen has announced the launch of Ducressa in the UK and Irela...
Continue Reading →
News

Evonetix commences access programme for synthesised DNA

Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform. Evonetix has announced the opening of its early access progra...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026